Monoclonal Antibodies and Small-Molecule Drugs: What General Neurologists Need to Know
This content is sponsored by Amgen Inc. and Novartis Pharmaceuticals Corporation.
April 3, 2020|Neurology
Click below to learn about monoclonal antibodies and small-molecule drugs, as well as some of the safety implications of their use in general neurology clinical practice.
